Sign In
to Vote &
Create Storyboards.
 
Eris Lifesciences gets Sebi nod for Rs2,000 crore IPO The Eris Lifesciences IPO will be yet another major exit for ChrysCapital, which has sold shares in Mankind Pharma and Intas Pharmaceuticals
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard